Skip to main content
. Author manuscript; available in PMC: 2010 May 10.
Published in final edited form as: Arch Intern Med. 2008 Nov 24;168(21):2326–2332. doi: 10.1001/archinte.168.21.2326

Table 3.

Association Between Pulmonary Scarring Detected by Baseline Chest Radiography and Subsequent Risk of Lung Cancer

Lung Cancers With Scarring, No. (%) Lung Cancer With Scarring in the Same/Opposite Lung, No./No.a Risk of Lung Cancer Associated With Scarring, HR (95%CI)b
Category Lung Cancer Cases, No. Overall Ipsilateral Lung Cancer Contralateral Lung Cancer
All lung cancer 809 122 (15.1) 91/75 1.5 (1.2-1.8) 1.8 (1.4-2.4) 0.9 (0.7-1.2)
Histologic subtype of lung cancer
    Adenocarcinoma 349 54 (15.5) 40/30 1.6 (1.2-2.2) 2.1 (1.4-3.2) 0.8 (0.5-1.3)
    Squamous cell carcinoma 152 24 (15.8) 21/20 1.3 (0.8-2.0) 1.5 (1.0-2.4) 1.4 (0.9-2.1)
    Small cell carcinoma 107 13 (12.1) 9/7 1.2 (0.6-2.1) 1.7 (0.8-3.6) 0.7 (0.3-1.6)
Follow-up interval after baseline, y
    0.01-2.00 268 37 (13.8) 28/24 1.3 (0.9-1.8) 1.6 (1.0-2.6) 0.9 (0.5-1.5)
    2.01-4.00 220 34 (15.5) 27/21 1.5 (1.1-2.2) 2.0 (1.2-3.3) 0.8 (0.5-1.5)
    4.01-6.00 143 24 (16.8) 17/13 1.8 (1.1-2.8) 2.1 (1.1-4.0) 0.8 (0.5-1.4)
    6.01-12.00 178 27 (15.2) 19/17 1.6 (1.1-2.4) 1.7 (0.9-3.2) 1.0 (0.5-2.0)

Abbreviations: CI, confidence interval; HR, hazard ratio.

a

Persons with bilateral scarring or bilateral cancer were counted as having scarring both in the same and in the opposite lung as the cancer. Persons with missing location data on scarring or cancer were not counted in these categories.

b

Hazard ratios are adjusted for age, sex, race/ethnicity, and smoking.